-
Cost Effectiveness Analysis of Lanadelumab vs C1 Inhibitor for Long-Term Prophylaxis of Hereditary Angioedema: A Brazilian Private Sector Perspective
Mar 10, 2025, 14:00 PM -
A Systematic Review of Economic Evaluations of Healthcare Associated Infection Prevention and Control Interventions in Long Term Care Facilities
Mar 10, 2025, 14:00 PM -
Prevalence of Claims-Reported Pruritus in Patients With Primary Biliary Cholangitis Overall and Among Those Treated With Obeticholic Acid
Mar 10, 2025, 14:00 PM -
Predicting Future Type 1 Diabetes Onset Risk; A Machine Learning Approach
Mar 10, 2025, 14:00 PM -
Budget Impact Model of Enhanced Lung Cancer Screening With AI/ML Tech-Based Software as a Medical Device (SaMD) on a US Cohort and Private Payer Perspective
Mar 10, 2025, 14:00 PM -
Systematic Literature Review (SLR) of Disease Burden Related to First-Line (1L) Unresectable, Locally Advanced, or Metastatic Gastric Cancer (GC) and Gastroesophageal Junction (GEJ) Adenocarcinoma
Mar 10, 2025, 14:00 PM -
Measuring Patient Engagement: The Importance of a Framework
Mar 10, 2025, 14:00 PM -
Real-World Adjuvant Nivolumab Utilization in Surgically Treated Muscle-Invasive Bladder Cancer Patients within U.S. Community Oncology Practice
Mar 10, 2025, 14:00 PM -
Differences in Demographic and Clinical Profiles Among Patients Adherent Vs. Non-Adherent to Revefenacin Following a COPD-Related Hospitalization
Mar 10, 2025, 14:00 PM -
Protocol for a Real-World Retrospective Study on Cardiovascular Outcomes in Japan Comparing Heated Tobacco Product Users, Cigarette Smokers, Former Smokers, and Never Smokers
Mar 10, 2025, 14:00 PM -
Development of Hungarian One-Day Surgical Care in the Public-Funded National Healthcare System From 2010 to 2023
Mar 10, 2025, 14:00 PM -
Association Between Vaginal Progesterone Use and Risk of Preterm Birth Among High-Risk Pregnancies: A Real-World Evidence Study
Mar 10, 2025, 14:00 PM -
A Real-World Analysis of Patient Cost Burden From COPD and Its Treatment Regimens
Mar 10, 2025, 14:00 PM -
Association of Chronic Conditions and Medication Burden with Patient Preferences for Long-Acting Antiretroviral Therapy in HIV Treatment
Mar 10, 2025, 14:00 PM -
The Social Distribution of Quality Adjusted Life Expectancy (QALE) Among Deprivation Subgroups in China
Mar 10, 2025, 14:00 PM -
Benchmarking Disease Prevalence in a Large Scale Electronic Health Record Data Network: An Assessment of Chronic and Rare Disease in the United States in 2023
Mar 10, 2025, 14:00 PM -
Leveraging Real-World Data Versus External Trials to Inform Comparative Efficacy within Single-Arm Trial-Based NICE Submissions
Mar 10, 2025, 14:00 PM -
A Targeted Literature Review of Value-Based Agreements (VBAs) for Cell and Gene Therapies in the United States
Mar 10, 2025, 14:00 PM -
Exploring the Broader Societal Value of Pembrolizumab in Triple-Negative Breast Cancer and Cervical Cancer in Brazil
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab for Previously treated MSI-H/dMMR Solid Tumors in Canada
Mar 10, 2025, 14:00 PM